Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
+$376M |
| 2 |
Truist Financial
TFC
|
+$149M |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$108M |
| 4 |
Alibaba
BABA
|
+$92.6M |
| 5 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$91.3M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
+$323M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$136M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$56.6M |
| 4 |
GWR
Genesee & Wyoming Inc.
GWR
|
+$41.5M |
| 5 |
VSM
Versum Materials, Inc.
VSM
|
+$39M |
Sector Composition
| 1 | Technology | 18.07% |
| 2 | Financials | 14.34% |
| 3 | Healthcare | 12.99% |
| 4 | Industrials | 10.14% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NPTN
2026
DELISTED
NEOPHOTONICS CORP
NPTN
| $4.87M | ﹤0.01% |
552,581
-6,278
| -1% | -$55.4K |
|
2027
Adecoagro
AGRO
$806M
| $4.86M | ﹤0.01% |
580,668
+43,207
| +8% | +$362K |
|
2028
America's Car Mart
CRMT
$286M
| $4.86M | ﹤0.01% |
44,316
-14,145
| -24% | -$1.55M |
|
2029
Virtu Financial
VIRT
$3.1B
| $4.85M | ﹤0.01% |
303,345
+8,206
| +3% | +$131K |
|
2030
Travere Therapeutics
TVTX
$2.09B
| $4.84M | ﹤0.01% |
340,511
+3,076
| +0.9% | +$43.7K |
|
|
GTHX
2031
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $4.83M | ﹤0.01% |
182,880
+3,141
| +2% | +$83K |
|
2032
Parsons
PSN
$8.18B
| $4.83M | ﹤0.01% |
117,011
+2,095
| +2% | +$86.5K |
|
2033
1st Source
SRCE
$1.55B
| $4.83M | ﹤0.01% |
92,994
-32,300
| -26% | -$1.68M |
|
2034
Axcelis
ACLS
$2.69B
| $4.82M | ﹤0.01% |
200,045
+2,479
| +1% | +$59.7K |
|
2035
CorVel
CRVL
$4.39B
| $4.82M | ﹤0.01% |
165,414
+1,674
| +1% | +$48.7K |
|
2036
Univest Financial
UVSP
$886M
| $4.81M | ﹤0.01% |
179,732
+3,496
| +2% | +$93.6K |
|
2037
Virtus Investment Partners
VRTS
$1.34B
| $4.8M | ﹤0.01% |
39,404
-857
| -2% | -$104K |
|
|
GMRE
2038
Global Medical REIT
GMRE
$512M
| $4.78M | ﹤0.01% |
361,411
+82,740
| +30% | +$1.09M |
|
2039
Banc of California
BANC
$2.62B
| $4.77M | ﹤0.01% |
277,587
+4,844
| +2% | +$83.2K |
|
|
PEI
2040
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
| $4.77M | ﹤0.01% |
59,621
+1,718
| +3% | +$137K |
|
2041
National Presto Industries
NPK
$802M
| $4.76M | ﹤0.01% |
53,827
+2,235
| +4% | +$198K |
|
|
NE
2042
DELISTED
Noble Corporation
NE
| $4.76M | ﹤0.01% |
3,898,472
+504,944
| +15% | +$616K |
|
|
XENT
2043
DELISTED
Intersect ENT, Inc
XENT
| $4.74M | ﹤0.01% |
190,496
+3,817
| +2% | +$95.1K |
|
2044
Antero Resources
AR
$10.2B
| $4.74M | ﹤0.01% |
1,661,116
+311,894
| +23% | +$889K |
|
2045
Alaunos Therapeutics
TCRT
$5.1M
| $4.72M | ﹤0.01% |
6,670
+157
| +2% | +$111K |
|
2046
Upland Software
UPLD
$71.6M
| $4.72M | ﹤0.01% |
132,200
+2,314
| +2% | +$82.6K |
|
|
ONIT
2047
Onity Group Inc.
ONIT
$367M
| $4.71M | ﹤0.01% |
229,220
+9,078
| +4% | +$187K |
|
2048
Great Southern Bancorp
GSBC
$710M
| $4.69M | ﹤0.01% |
73,984
-4,663
| -6% | -$295K |
|
|
EXTN
2049
DELISTED
Exterran Corporation
EXTN
| $4.67M | ﹤0.01% |
595,833
+131,576
| +28% | +$1.03M |
|
2050
BridgeBio Pharma
BBIO
$9.79B
| $4.66M | ﹤0.01% |
133,031
+6,788
| +5% | +$238K |
|